Recent Highlights: "Standard BioTools delivered a solid first quarter in line with our expectations, reflecting focused execution in a challenging Life Sciences macro backdrop," said Michael Egholm, PhD, President and Chief Executive Officer of Standard BioTools. "We remain grounded and disciplined, driving a 29% year-over-year improvement in adjusted EBITDA through Standard BioTools Business System (SBS). We believe our unique model, world class operational platform and healthy capital position will allow ...

Exhibit 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE Investor Relations Contact: Daniel E. Bachus Chief Financial Officer Grand Canyon Education, Inc. 602-639-6648 Dan.bachus@gce.com GRAND CANYON EDUCATION, INC. REPORTS FIRST QUARTER 2025 RESULTS PHOENIX, AZ., May 6, 2025—Grand Canyon Education, Inc. (NASDAQ: LOPE), ("GCE" or the "Company"), is a publicly traded education services company that currently provides services to 22 university partners. GCE provides a full array of support services in the post-seconda ...

Exhibit 99.1 Kulicke & Soffa Pte. Ltd. 23A Serangoon North Ave 5 Singapore 554369 +65 6880-9600 main Co. Regn. No. 199902120H Kulicke and Soffa Industries, Inc. 1005 Virginia Drive Fort Washington, PA 19034 USA +1-215-784-6000 main www.kns.com Kulicke & Soffa Reports Second Quarter 2025 Results Singapore – May 6, 2025 – Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) ("Kulicke & Soffa," "K&S," "our," or the "Company"), today announced financial results of its second fiscal quarter ended March 29, 2025. Th ...

loanDepot announces first quarter 2025 financial results Q1 was a quarter of positive momentum for the company. Higher volume, margins and ongoing cost discipline drive improved Q1 results. Company Founder and Executive Chairman Anthony Hsieh also returned to the company's day-to-day operations in Q1; Hsieh will focus on expanding originations and driving innovation through tech enablement. Current CEO Frank Martell set to transition to a board advisory role in June; Hsieh will assume interim CEO role at th ...

Exhibit 99.1 eXp World Holdings Reports Q1 2025 Results BELLINGHAM, Wash. — May 6, 2025 — eXp World Holdings, Inc. (Nasdaq: EXPI), "eXp" or the "Company", "the most agent-centric™" real estate brokerage on the planet and the core subsidiary of eXp World Holdings, Inc., today announced financial results for the first quarter ended March 31, 2025. "We're entering 2025 from a position of strength. eXp has built one of the most comprehensive, tech-enabled agent value stack in the industry – one that's driving r ...

Exhibit 99.1 Intapp Announces Third Quarter Fiscal Year 2025 Financial Results PALO ALTO, Calif., May 6, 2025 – Intapp, Inc. (NASDAQ: INTA), a leading global provider of AI-powered solutions for professionals at advisory, capital markets, and legal firms, announced financial results for its fiscal third quarter ended March 31, 2025. Intapp also provided its outlook for the fourth quarter and the full fiscal year 2025. "We are pleased to report a strong third quarter in which our clients continued to adopt a ...

Exhibit 99.1 Upstart Announces Results for First Quarter 2025 SAN MATEO, Calif. – May 6, 2025 – Upstart Holdings, Inc. (NASDAQ: UPST), the leading artificial intelligence (AI) lending marketplace, today announced financial results for the quarter ended March 31, 2025. Upstart will host a conference call and webcast at 1:30 p.m. Pacific Time today. An earnings presentation and link to the webcast are available at ir.upstart.com. "With an unparalleled pace of innovation, we continue to raise the bar in AI-ena ...

Exhibit 99.1 WEYCO REPORTS FIRST QUARTER SALES AND EARNINGS Milwaukee, Wisconsin---May 6, 2025---Weyco Group, Inc. (NASDAQ: WEYS) ("we," "our," "us" and the "Company") today announced financial results for the quarter ended March 31, 2025. Retail gross earnings as a percent of net sales were 66.6% and 65.3% in the first quarters of 2025 and 2024, respectively. Retail operating earnings totaled $0.6 million for the quarter, down 52% from $1.3 million last year. The decrease was primarily due to lower sales. ...

Exhibit 99.1 CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3 -Initial CTX310™ Phase 1 clinical data demonstrates dose-dependent decreases in triglycerides (TG) and low- density lipoprotein (LDL), with peak reduction of up to 82% in TG and up to 81% in LDL, with a well-tolerated safety profile; presentation anticipated at a medical meeting in the second half of 2025- -CASGEVY® continues to gain mom ...

Enrollment Completed in ACACIA-HCM; Topline Results Expected in 1H 2026 CYTOKINETICS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE PDUFA Date for Aficamten in Obstructive HCM Extended by FDA to December 26, 2025 Topline Results from MAPLE-HCM Expected in May ~$1.1 Billion in Cash, Cash Equivalents and Investments as of March 31, 2025 SOUTH SAN FRANCISCO, Calif., May 06, 2025 - Cytokinetics, Incorporated (Nasdaq: CYTK) reported a management update and financial results for the fir ...